# Alleima account plan

> Alleima is a Swedish maker of advanced stainless steels, special alloys, industrial heating and medical wire, with FY2025 revenues of SEK 18,630 million.

## At a glance

Alleima develops and manufactures high value-added products in advanced stainless steels and special alloys, industrial heating products and ultra-fine medical wire, on a fully integrated value chain from melting to finishing. It sells in more than 80 countries to Oil and Gas (23% of 2025 revenues), Industrial, Chemical and Petrochemical, Industrial Heating, Medical, Nuclear and other segments, with the USA, China and Sweden its largest markets. In FY2025 revenues were SEK 18,630 million (19,691) and adjusted EBIT SEK 1,555 million (margin 8.3%), with a total workforce of about 6,800. Alleima is listed on Nasdaq Stockholm; Industrivärden (21.09%) and Lundbergföretagen (10.04%) are the largest shareholders.

## Business units

- **Tube** (about 70% of FY2025 revenue (SEK 13,063 million)): Seamless tubes and long products in advanced stainless steels and special alloys for Oil and Gas, Chemical and Petrochemical, Industrial, Nuclear and Transportation, made mainly in Sandviken, Chomutov, Scranton, Mehsana and Zhenjiang. Adjusted EBIT margin was 8.9% in FY2025 but fell to 1.4% in Q3 2026 on OCTG under-absorption and lower nuclear production. It is led by Carl von Schantz.
- **Kanthal** (about 21% of FY2025 revenue (SEK 3,996 million)): Industrial heating technology and resistance materials, plus ultra-fine wire, components and nitinol for medical devices such as glucose monitors and pacemakers. It is the growth engine: Q3 2026 revenues rose 12% and the adjusted EBIT margin reached 19.4%, driven by electronics, semiconductors and medical. It is led by Robert Stål.
- **Strip** (about 8% of FY2025 revenue (SEK 1,571 million)): Precision strip steel, compressor valve steel and pre-coated strip for hydrogen fuel cells, produced in Sandviken with service centers in the US, Japan and China. Adjusted EBIT was SEK -15 million in Q3 2026 (margin -4.3%), and targeted initiatives aim to improve profitability and delivery accuracy. It is led by Per Eklund.

## Strategic priorities

- **Shift to prioritized segments**: Capital goes to Nuclear, Chemical and Petrochemical, Medical, Industrial Heating and Hydrogen and Renewable Energy, which were 43% of revenues in 2025 against an ambition of 45-50% by 2030.
- **Nuclear capacity**: Reopening the Sandviken steam generator tube plant raises capacity by about 60%, with first deliveries scheduled for late 2026; Alleima supplies tubes for SMRs and booked orders for Sizewell C in the UK.
- **Cost discipline**: A cost programme launched in October 2025 targets annual savings of approximately SEK 200 million with full effect by the end of 2026; it contributed approximately SEK 40 million in Q3 2026.
- **Local-for-local growth in Asia**: Alleima completed a new Tube line in Zhenjiang, China, and is investing SEK 220 million in Mehsana, India, for Chemical and Petrochemical and CNG tubing, as part of a strategy built on technology leadership and locally produced premium.
- **Financial targets**: Organic growth in line with or above targeted end-markets, an adjusted EBIT margin above 9% on average over a cycle, net debt/equity below 0.3x and a 50% average payout.
- **Sustainability**: Scope 1 and 2 CO2 down more than 54% by 2030 (SBTi-approved), TRIFR down more than 50% by 2030 vs 2019, and more than 80% recycled steel (82.3% in Q3 2026).

## Latest results

In Q3 2026 (published October 26, 2026) revenues were SEK 4,257 million (4,222), +1% but -2% organic, and rolling 12-month order intake was SEK 17,976 million, -4%, after an OCTG order of approximately SEK 250 million was cancelled. Adjusted EBIT was SEK 202 million (197), a margin of 4.8% (4.7), and free operating cash flow rose to SEK 373 million (285). Kanthal carried earnings while Tube's margin fell to 1.4% and Strip lost money. For the nine months, revenues were SEK 13,729 million (-3%) and adjusted EBIT SEK 1,107 million, margin 8.1% (8.4). For Q4 2026 Alleima expects OCTG under-absorption and a lower nuclear production rate to weigh, a positive currency effect of approximately SEK 100 million on EBIT, and 2026 capex of approximately SEK 1,000 million.

## Investments and deals

- **Sandviken nuclear tube mill**: Reopening of Tube Mill 68 for steam generator tubes, raising capacity by about 60% toward end-2026.
- **Mehsana, India**: SEK 220 million for further processing and finishing for Chemical and Petrochemical, CNG fuel system and hydraulic and instrumentation tubing, announced with the Q3 2026 report.
- **Medical and Industrial Heating capacity**: A medical wire plant in Malaysia, Industrial Heating expansions in Japan, the US and Scotland, and the Endox acquisition (medical) completed January 14, 2025 for a net cash outflow of SEK 147 million.
- **Capex level**: Capex was SEK 1,089 million in FY2025 and is guided at approximately SEK 1,000 million for 2026, cut from SEK 1,100 million for timing reasons.
- **Electric process gas heating**: The Prothal electric process gas heater, in partnership with Danieli, has a first commercial pilot for Emsteel's DRI plant in Abu Dhabi, with an aim of a commercial solution of several hundred megawatts by 2027.

## Challenges and risks

- **Stalled OCTG market**: Oil and Gas is the largest segment, and OCTG weakened with the Middle East conflict, causing under-absorption in Tube and an order cancellation of approximately SEK 250 million.
- **Nuclear execution**: Lower-than-planned nuclear production in Q3 2026 came from one fixed-price order in an unusual steam generator tube dimension.
- **Weak short-cycle and European demand**: Industrial is weak and Europe-dependent, Chemical and Petrochemical is weaker in China, and Europe faces higher energy costs.
- **Tariffs, currency and geopolitics**: Negative currency effects of SEK 341 million hit FY2025 adjusted EBIT, and US import tariffs and the conflict around Iran are flagged as risks to supply chains, trade flows and energy and transport costs.
- **Production disruptions**: A summer press replacement in Sandviken in 2025 caused ramp-up problems that hurt Q3 and Q4 revenues and profitability.

## What leadership says

> "Our strong financial position has enabled us to be selective and strategic in our order intake" — Göran Björkman, President and CEO, CEO statement, Alleima Annual Report 2025, March 2026

> "You can never beat Chinese players on cost. Instead, we focus on technology leadership and locally produced premium." — Göran Björkman, President and CEO, EFN interview, December 23, 2025 (translated from Swedish)

> "That area is 20-30 percent of Kanthal's heating business and the one growing fast." — Göran Björkman, President and CEO, On semiconductor and data center heating, Nyhetsbyrån Direkt interview, October 26, 2026 (translated from Swedish)

> "The margin was 4.8 percent, in line with last year, but is not where I think we should be." — Göran Björkman, President and CEO, Nyhetsbyrån Direkt interview after the Q3 2026 report, October 26, 2026 (translated from Swedish)


## Where a supplier can help

- **Plant uptime and absorption**: Under-absorption in Tube and the Sandviken ramp-up problems point to maintenance, automation and production-planning suppliers that help a high-fixed-cost mill run steadily.
- **Capacity projects in India, Malaysia and Sweden**: The Mehsana investment, the Malaysian medical plant and the nuclear tube mill reopening need equipment, engineering, quality and commissioning partners.
- **Cost programme support**: The SEK 200 million annual savings target opens room for procurement, energy-cost and process-efficiency offers, especially with European energy costs rising.
- **Kanthal growth in semiconductors and medical**: Fast growth in electric heating for electronics and semiconductors and in medical wire calls for capacity, materials supply and regulatory and quality services.
- **Trade and supply-chain resilience**: US tariffs, the Middle East conflict and the local-for-local strategy create demand for trade compliance, logistics and supply-chain risk tools.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Alleima Annual Report 2025](https://www.alleima.com/siteassets/documents/ir/2025-ar/alleima-annual-report-2025.pdf)

Annual report · 2026-03-23

- Alleima is a Swedish advanced-materials group (listed on Nasdaq Stockholm) making high value-added products in advanced stainless steels and special alloys, industrial heating products and medical wire; ~6,800 total workforce, sales in more than 80 countries, >900 active alloys, 81% recycled steel in production.
- FY2025: revenues SEK 18,630 million (19,691), organic growth 0%; adjusted EBIT SEK 1,555 million (1,944), margin 8.3% (9.9); excluding SEK 341 million of negative currency effects the adjusted margin was 9.8%. Order intake fell 9% to SEK 17,741 million (organic -4%), book-to-bill 95%.
- Three divisions: Tube (SEK 13,063 million revenues, adj. EBIT margin 8.9%), Kanthal (SEK 3,996 million, 16.4%) and Strip (SEK 1,571 million, 3.9%). Oil and Gas is the largest customer segment (23% of revenues in Note 2), then Industrial (17%) and Chemical and Petrochemical (16%).
- Strategy: shift the product mix toward prioritized segments (Industrial Heating, Medical, Chemical and Petrochemical, Nuclear, Hydrogen and Renewable Energy), from 43% of revenues in 2025 to an ambition of 45-50% by 2030; addressable market seen growing 6% per year.
- Growth investments: new Tube line in Zhenjiang (China) completed; Sandviken plant reopening raises nuclear steam generator tube capacity by ~60% toward end-2026; medical wire plant in Malaysia; Industrial Heating expansions in Japan, the US and Scotland; Endox (medical) acquired in January 2025.
- Cost programme launched October 2025: savings of just over SEK 200 million a year, one-off costs of nearly SEK 400 million (mostly in Q4 2025); a summer press replacement in Sandviken caused ramp-up problems that hurt Q3 and Q4.
- Strong balance sheet: net cash (net debt SEK -864 million, net debt/equity -0.05), free operating cash flow SEK 1,100 million, capex SEK 1,089 million; proposed dividend SEK 2.50 per share (71% of profit adjusted for metal price effects).
- Long-term targets: organic growth in line with or above targeted end-markets, adjusted EBIT margin above 9% on average over a cycle, net debt/equity below 0.3x, 50% average payout; CEO Göran Björkman frames 2025 as a challenging year in which Alleima stayed "selective and strategic in our order intake".

### [Alleima Interim report Q3 2026](https://www.alleima.com/siteassets/documents/ir/2026-q3/alleima-q3-2026.pdf)

Interim report · 2026-10-26

- Q3 2026 revenues SEK 4,257 million (4,222), +1%, organic -2%; rolling 12-month order intake SEK 17,976 million (18,665), -4%, organic -1%; book-to-bill 99%.
- Adjusted EBIT SEK 202 million (197), margin 4.8% (4.7); reported EBIT SEK 315 million (127) helped by SEK 107 million of positive metal price effects; free operating cash flow SEK 373 million (285).
- Kanthal is the engine: revenues +12% (organic +10%), adjusted EBIT SEK 226 million, margin 19.4% (16.1), R12 order intake +11% with organic +18%, on electric heating for electronics/semiconductors and medical products.
- Tube weak: adjusted EBIT SEK 40 million, margin 1.4% (3.6), on under-absorption in OCTG and lower-than-planned nuclear production; an OCTG order of approximately SEK 250 million was cancelled and booked as negative order intake.
- Strip loss-making: adjusted EBIT SEK -15 million, margin -4.3%; revenues -8%.
- Nine months: revenues SEK 13,729 million (-3%), adjusted EBIT SEK 1,107 million, margin 8.1% (8.4), with SEK -77 million of currency impact.
- Investments continue: SEK 220 million in Mehsana, India (Chemical and Petrochemical, CNG precision tubing); 2026 capex guided at approximately SEK 1,000 million; cost measures contributed approximately SEK 40 million in the quarter.
- Outlook Q4 2026: OCTG under-absorption and lower nuclear production rate weigh; positive currency effect of approximately SEK 100 million on EBIT expected; Middle East conflict and US tariffs flagged as risks.

### [Alleimas vd: Geopolitiken fortsätter påverka efterfrågan (EFN)](https://efn.se/alleimas-vd-geopolitiken-fortsatter-paverka-efterfragan)

Executive talk · Göran Björkman, President and CEO · 2025-12-23

- Interview with CEO Göran Björkman by EFN (published December 23, 2025), held at the Sandviken steelworks and head office; quotes translated from Swedish.
- On 2025: he expected a better year but geopolitical turbulence, tariffs and currency weigh on demand; Europe is still weak, the US regional business has slowed, and Alleima is "basically flat organically this year" (translated).
- Response is discipline: cost efficiency, capacity and innovation; a SEK 200 million a year savings package is being implemented.
- Nuclear is "really back": reopening the steam generator tube plant (closed after Fukushima) lifts capacity by 60%; business seen in plant life extensions and potentially SMRs, and Alleima follows next-generation reactors cooled by salt, molten lead or helium.
- Medical technology (wire and components for pacemakers, glucose monitors, neurostimulation) has quadrupled in five years, with new production opening in Malaysia; thermal spray is a new capability.
- China: Alleima cannot beat Chinese players on cost, so it focuses on technology leadership and locally produced premium; much of the world's technology development now happens in China.
- 9% adjusted EBIT margin target kept; he says the company has "far from exhausted" its potential, and that independence from Sandvik gave Alleima control over capital allocation.

### [Alleima: Verksamhet inom halvledare/datacenter går starkt - vd (Nyhetsbyrån Direkt, Placera)](https://www.placera.se/telegram/alleima-verksamhet-inom-halvledare-datacenter-gar-starkt-vd-20261026)

Executive talk · Göran Björkman, President and CEO · 2026-10-26

- Short interview of CEO Göran Björkman with Nyhetsbyrån Direkt (via Placera) on October 26, 2026, after the Q3 2026 report sent the share down 8%; quotes translated from Swedish.
- Kanthal's semiconductor and data center heating business is 20-30% of Kanthal's heating business and growing fast; he expects growth to continue while data centers are built and semiconductors are scarce.
- Strong segments: umbilical tubing, nuclear, industrial heating, aerospace and medical technology; the drop in rolling 12-month order intake to -1% is mainly timing, given project-driven business, with a good October for umbilical and nuclear orders.
- He is not satisfied: the 4.8% margin "is not where I think we should be"; Q3 is always the weakest quarter (maintenance stops, under-absorption), with OCTG particularly weak due to the Middle East.
- Chemical and Petrochemical: China weaker (also for competitors), India growing very strongly; Europe faces higher energy costs this winter. Industrial is weak and Europe-dependent.
- Nuclear: problems tied to one fixed-price order in an unusual steam generator tube dimension; good orders booked for Sizewell C in the UK.
- Capex guidance cut from SEK 1,100 million to SEK 1,000 million is "more timing", not new decisions.

## Questions about Alleima

### What does Alleima do?

Alleima makes high value-added products in advanced stainless steels and special alloys, industrial heating products and ultra-fine medical wire, through three divisions: Tube, Kanthal and Strip.

### What is Alleima's revenue?

Revenues were SEK 18,630 million in FY2025 (19,691), with adjusted EBIT of SEK 1,555 million. Nine-month 2026 revenues were SEK 13,729 million.

### How many employees does Alleima have?

Alleima had a total workforce of about 6,800 in 2025, with 6,380 employees at year-end.

### What is Alleima's strategy?

Alleima is shifting its mix toward prioritized segments such as Nuclear, Medical, Industrial Heating and Chemical and Petrochemical, aiming for 45-50% of revenues by 2030, while targeting an adjusted EBIT margin above 9% over a cycle.

### Who leads Alleima?

Göran Björkman is President and CEO, Johan Eriksson is CFO, and Andreas Nordbrandt is Chairman.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
